http://archive.fast-edgar.com/20260929/AOBZO22D8C226TZ2222Q2ZZZD7OCZ2Q2DL82
Filed on: September 29, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of September 2026 (Report No. 2)
Commission file number: 001-41387
SaverOne 2014 Ltd.
(Translation of registrant’s name into English)
Em Hamoshavot Rd. 94
Petah Tikvah, Israel
(Address of principal executive offices)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE TO
TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1)
OF THE SECURITIES EXCHANGE ACT OF 1934
Amendment No. 1
ACV AUCTIONS INC.
(Name of Subject Company (Issuer))
APPLE MERGER SUB, INC.
(Offeror)
A Wholly Owned Subsidiary of
COPART, INC.
(Parent of Offeror)
(Names of Filing Persons (identifying status as offeror, issuer or other person))
Common... (continue reading...)
More SEC Filings
View Older Stories-
Form S-3ASR MERCANTILE BANK CORP
-
Form 6-K MINISO Group Holding For: Sep 29
-
Form D/A MCorp a Series of CGF202
-
Form 8-K Imunon, Inc. For: Sep 28
-
Form 8-K TOP Financial Group Ltd For: Sep 25
-
Form 8-K Bloomin' Brands, Inc. For: Sep 25
-
Form 8-K FIRST UNITED CORP/MD/ For: Sep 24
-
Form 8-K Allarity Therapeutics, For: Sep 28
-
Form 8-K SurgePays, Inc. For: Sep 28
-
Form RW Syra Health Corp
-
Form 6-K POWERBANK Corp For: Sep 29
-
Form 8-K ATOSSA THERAPEUTICS, For: Sep 29
-
Form 6-K RoyaLand Co Ltd. For: Sep 29
-
Form 8-K TransDigm Group INC For: Sep 28
-
Form N-23C-2 OFS Credit Company, Inc. For: Sep 29
-
Form 497J Tidal Trust I
-
Form D/A Sensori April 2026 a
-
Form D/A Dart Financial Corp
-
Form D/A Auvi Labs Heinz Ventures
-
Form 485BXT GraniteShares ETF Trust
-
Form 40-17F2 BNY MELLON HIGH YIELD Filed by: BNY MELLON HIGH YIELD STRATEGIES FUND
-
Form 40-17F2 BNY Mellon Investment Filed by: BNY Mellon Investment Funds I
-
Form 40-17F2 BNY Mellon Investment Filed by: BNY Mellon Investment Funds II, Inc.
-
Form 40-17F2 BNY Mellon Investment Filed by: BNY Mellon Investment Funds III
-
Form 40-17F2 BNY Mellon Investment Filed by: BNY Mellon Investment Funds IV, Inc.
-
Form NT 10-K VISIUM TECHNOLOGIES, For: Jun 30
-
Form 8-K Unicycive Therapeutics, For: Sep 28
-
Form D/A Declan Odyssey X a Serie
-
Form 8-K SOUNDTHINKING, INC. For: Sep 28
-
Form 485BXT GraniteShares ETF Trust
-
Form 424B2 TORONTO DOMINION BANK
-
Form D/A PRIVATEAIINVESTMENTSVLLC
-
Form 485BXT GraniteShares ETF Trust
-
Form 6-K Charming Medical Ltd For: Sep 29
-
Form 6-K Metalpha Technology Hold For: Sep 29
-
Form 18-K/A ONTARIO PROVINCE OF For: Mar 31
-
Form 6-K Glass House Brands Inc. For: Sep 29
-
Form 6-K Almonty Industries Inc. For: Sep 29
-
Form D VIRELTO LTD.
-
Form 8-K Cartesian Therapeutics, For: Sep 29
-
Form 6-K Central North Airport For: Sep 29
-
Form 6-K One & one Green Technolo For: Jun 30
-
Form 20-F Gamehaus Holdings Inc. For: Jun 30
-
Form 6-K MIXED MARTIAL ARTS GROUP For: Sep 29
-
Form 6-K Optimi Health Corp. For: Sep 29
-
Form 4 Qfin Holdings, Inc. For: Sep 29 Filed by: Yan Andrew Y
-
Form 8-K Invivyd, Inc. For: Sep 29
-
Form FWP Immix Biopharma, Inc. Filed by: Immix Biopharma, Inc.
-
Form 424B5 Immix Biopharma, Inc.
-
Form 8-K Aquestive Therapeutics, For: Sep 29

